Contents

Central Nervous System Agents in Medicinal Chemistry , Volume 12 - Number 3

Editorial

Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]

, 12(3): 153 - 157

Mohtashem Samsam


DOI: 10.2174/187152412802430101




Central Nervous System Acting Drugs in Treatment of Migraine Headache

, 12(3): 158 - 172

Mohtashem Samsam


DOI: 10.2174/187152412802430147




GEMSP: A New Therapeutic Approach to Multiple Sclerosis

, 12(3): 173 - 181

Michel Geffard, Sebastien Duleu, Alban Bessede, Valerie Vigier, Dominique Bodet, Arturo Mangas and Rafael Covenas


DOI: 10.2174/187152412802430110




A Role of Immunotherapy in Metastatic Malignant Melanoma

, 12(3): 182 - 188

Timothy Allen and Lavanya Gundrajakuppam


DOI: 10.2174/187152412802430165




Melatonin and Synthetic Melatonergic Agonists: Actions and Metabolism in the Central Nervous System

, 12(3): 189 - 216

R. Hardeland and B. Poeggeler


DOI: 10.2174/187152412802430129




Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates

, 12(3): 217 - 232

Tiago Campos Pereira and Iscia Lopes-Cendes


DOI: 10.2174/187152412802430138




The Atypical Cannabinoid O-1602: Targets, Actions, and the Central Nervous System

, 12(3): 233 - 239

John C. Ashton


DOI: 10.2174/187152412802430156




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science